HeyJaredBerkeley Lovelace Jr
- Indexed articles, last 90 days
- 100
- Latest publication
- Sep 30, 2026
- Outlet visibility, for NBC Los Angeles
- Top 500K sites
- Earliest in this view
- Jul 20, 2026
Latest articles
People With Type 2 Diabetes Lost up to 60 Pounds on Lilly’s Latest Weight Loss Drug (opens the original)
Read excerpt
Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published Tuesday in The Lancet. It’s the most weight loss ever recorded in a drug trial for diabetes patients, a group that often has a harder time losing weight. In clinical trials for semaglutide and tirzepatide, people with Type 2 diabetes lost up to 10% (21 pounds) and 15% (34 pounds) of their body weight, res
People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug (opens the original)
Read excerpt
Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published Tuesday in The Lancet. It’s the most weight loss ever recorded in a drug trial for diabetes patients, a group that often has a harder time losing weight. Stream NBC4 newscasts for free right here, right now. In clinical trials for semaglutide and tirzepatide, people with Type 2 diabetes lost up to 10% (21
People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug (opens the original)
Read excerpt
Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published Tuesday in The Lancet. It’s the most weight loss ever recorded in a drug trial for diabetes patients, a group that often has a harder time losing weight. Stream San Diego News for free, 24/7, wherever you are with NBC 7. In clinical trials for semaglutide and tirzepatide, people with Type 2 diabetes lost
People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug (opens the original)
Read excerpt
Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published Tuesday in The Lancet. It’s the most weight loss ever recorded in a drug trial for diabetes patients, a group that often has a harder time losing weight. Stream Los Angeles News for free, 24/7, wherever you are. In clinical trials for semaglutide and tirzepatide, people with Type 2 diabetes lost up to 10%
People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug (opens the original)
Read excerpt
Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published Tuesday in The Lancet. It’s the most weight loss ever recorded in a drug trial for diabetes patients, a group that often has a harder time losing weight. Stream Connecticut News for free, 24/7, wherever you are. In clinical trials for semaglutide and tirzepatide, people with Type 2 diabetes lost up to 10%
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For NBC Los Angeles, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.